Accurate measurement of protein affinity and stability is an essential component of drug development, starting from early design to late formulation. When it comes to collecting data, who does not want fast, faster, and fully automated?!
NanoTemper Technologies offers MicroScale Thermophoresis (MST) and nanoDSF technology to analyze these parameters in an easy and precise way. To meet the increasing demand for high-throughput applications and unattended operation, NanoTemper Technologies provides fully automated MST and nanoDSF platforms — and combinations of both.
Together with our partners Hamilton Robotics and Peak Analysis & Automation, we invite you to join the Biopharma Workshop 2016 in Basel, as an event opener for MipTec 2016 (September 19, 2016; Ramada Hotel, Basel, Switzerland).
As the event is coming closer, we tailored a thrilling agenda filled with guest speaker presentations from renowned biopharmaceutical companies. One of the highlights will be the official launch of our new software packages for advanced protein stability analysis.
Learn more about the applications of MST and nanoDSF in drug discovery, and how they are integrated into industry workflows. Do not miss presentations by scientists from renowned biopharmaceutical companies; it is a unique opportunity to see how your peers optimize their drug discovery programs for speed and efficiency.
- Dr. Patrick Sieber, Actelion Pharmaceuticals, Switzerland
- Dr. Matthias Haffke, Novartis Institutes for Biomedical Research, Switzerland
- Dr. Tim Menzen, Coriolis Pharma, Germany
- Dr. Klaus Rumpel, Boehringer Ingelheim, Austria
Unique technology identifies drug candidates, speeds up drug development